Skip to content

Single Site Versus Multi Site Robotic Hysterectomy

Single Site Versus Multi Site Robotic Hysterectomy

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03662451
Enrollment
0
Registered
2018-09-07
Start date
2024-10-15
Completion date
2026-11-01
Last updated
2024-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative, Rehabilitation, Wound Infection

Keywords

Return-to-work, Cosmesis, Visual analogue pain score

Brief summary

Robotic single site surgery (R-SSH) is a novel technique, which may be superior to multi site hysterectomy (R-MSH) in select patients regarding cosmesis and postoperative pain. A randomized trial is performed to compare R-SSH with R-MSH with regard to the postoperative rehabilitation, cosmesis, the operational cost, and the perioperative morbidity.

Detailed description

The study is scheduled to start November 2018 and compares robotic single site to multi site hysterectomy. Procedures are performed on two locations, Herning and Herlev Hospitals, by experienced surgeons. Patients are randomized to either R-SSH (No.=62) or R-MSH (No.=62). Patient's satisfaction with body image and cosmesis is assessed at different time points pre- and postoperatively by means of validated cosmesis scales and Body Image Questionnaire and photo-evaluations. Postoperative pain and split times spent at the operation theatre will be registered as secondary outcome parameters. A follow-up at 1, 3 and 6 month include evaluation of the scar and registration of port-site hernias and vaginal dehiscence or other complications. Interviews and diaries will include time of return to home and work, daily activities including sexuality The R-SSH is performed using da Vinci, Xi robotic system. One single port, diameter 2 cm is applied. Applying an additional assistant port is defined conversion of procedure R-MSH is performed using standard equipment and 4 trocars, 5 mm each. Sample size calculation was based a previous study on fast track hysterectomy, which showed a difference in return to work of 4 days. 62 women in each group is needed with standard deviation ±8 and a power of 80%. To include those not working, the calculation was performed with an expected visual analog pain score of 0.86 ±0.2 and 62 in each group and suggested that the sample was sufficient to detect of difference of 0.1 in visual analog pain score with a power of 80%. All calculation are based on two-sided testing with alpha of 0.05.

Interventions

PROCEDURERobotic assisted hysterectomy

Periumbilical single incision vs multiple abdominal incisions for hysterectomy

Sponsors

Herlev Hospital
CollaboratorOTHER
Herning Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Women are randomized to either robotic single site or multi site hysterectomy

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Hysterectomy on benign indication, * American Society of Anesthetists group 1 or 2, * BMI less than 30 kg/m2 * uterine size less than 300 g estimated by ultrasound, using Ferraris formula.

Exclusion criteria

* adhesions * prior extensive abdominal surgery * prior midline incision * cutis laxa of abdomen surgery * endometriosis * more than 1 cesarean section * malignant disease

Design outcomes

Primary

MeasureTime frameDescription
Scar appearance and satisfactionSix months after operationAppearance and evaluation of scar by POSAS scale (see www.posas.org and reference below) which has a scale from 1-10, where 1 is minimum and 10 is maximum; on scar's pain, its itching, on difference from normal skin, on stiffness, on thickness, on irregularity and general satisfaction

Secondary

MeasureTime frameDescription
Scoring of abdominal painVisual analogue pain score at first, second, third, fourth, fifth, and sixth month after operationVisual analogue pain score with a minimum '0' and maximum '10'

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026